Literature DB >> 26462637

[Effects of peri-immunosupressive therapy period infection on hematologic response and survival of severe aplastic anemia].

Lei Ye1, Liping Jing1, Wenrui Yang1, Kang Zhou1, Guangxin Peng1, Yang Li1, Yuan Li1, Jianping Li1, Lin Song1, Zhijie Wu1, Fengkui Zhang1, Li Zhang1.   

Abstract

OBJECTIVE: To explore the effects of peri-immunosuppressive treatment(IST)infection on outcomes of severe and very severe aplastic anemia(SAA/VSAA)patients.
METHODS: Medical record and follow-up data of 105 SAA/VSAA who underwent first-line IST were retrospectively analyzed to find out the characters of infections(1 month before to 3 months after IST), and its effects on hematologic response and survival.
RESULTS: Of 105 patients, a total of 270 febrile episodes were recorded in 97 patients(92.4%)during their peri- IST periods, with the median infections of 2(1-7)episodes in each patient with the median febrile duration of 7(1-47)days. Respiratory system(35.1%)was the primary anatomic site of infection. Bacteria(88.2%)were common causes of total 169 pathogenic bacteria in 96 clear pathogenic bacteria episodes. And patients who got infection 1 month before IST had much lower 6- month hematologic response rate than their counterpart ones(50.8% vs 80.0%, P=0.004). Multiple febrile episodes ( ≥3 times) and the total febrile duration ≥4 days showed the best sensitivity and specificity according to the ROC curve analysis. The 5-year overall survival of the 105 patients was 76%. The 5- year OS of patients with multiple febrile episodes ( ≥3 times) were much lower than their counterpart ones[(59.6±7.2)% vs(89.5±4.0)%](P<0.01). The 5-year OS of the total febrile duration ≥4 days was much lower than their counterpart ones[(63.4±5.8)% vs 100.0%](P<0.01).
CONCLUSION: Infections 1 month before IST were associated with hematologic response. Multiple febrile episodes(≥3 times) and infections with the febrile duration ≥4 days presented inferior hematologic response and survival.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26462637     DOI: 10.3760/cma.j.issn.0253-2727.2015.08.009

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  1 in total

1.  [How I treat refractory sever aplastic anemia].

Authors:  F K Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.